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Neurobiology of Disease
Overexpression of the Steroidogenic Enzyme Cytochrome
P450 Side Chain Cleavage in the Ventral Tegmental Area
Increases 3,5-THP and Reduces Long-Term Operant
Ethanol Self-Administration
Jason B. Cook,1,2 David F. Werner,1,6 Antoniette M. Maldonado-Devincci,1 Maggie N. Leonard,1 Kristen R. Fisher,1
Todd K. O’Buckley,1 Patrizia Porcu,1,7 Thomas J. McCown,3,5 Joyce Besheer,1,2,3 ClydeW. Hodge,1,2,3,4
and A. Leslie Morrow1,2,3,4
1Bowles Center for Alcohol Studies, 2Curriculum in Neurobiology, 3Departments of Psychiatry and 4Pharmacology, and 5Gene Therapy Center, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, 6Department of Psychology, Center for Development and Behavioral Neuroscience,
Binghamton University– State University of New York, Binghamton, New York 13902, and 7Institute of Neuroscience, National Research Council of Italy,
09129 Cagliari, Italy
Neuroactive steroids are endogenous neuromodulators capable of altering neuronal activity and behavior. In rodents, systemic admin-
istration of endogenous or synthetic neuroactive steroids reduces ethanol self-administration. We hypothesized this effect arises from
actionswithinmesolimbic brain regions that we targeted by viral gene delivery. CytochromeP450 side chain cleavage (P450scc) converts
cholesterol to pregnenolone, the rate-limiting enzymatic reaction in neurosteroidogenesis. Therefore, we constructed a recombinant
adeno-associated serotype 2 viral vector (rAAV2), which drives P450scc expression and neuroactive steroid synthesis. The P450scc-
expressing vector (rAAV2-P450scc) or control GFP-expressing vector (rAAV2-GFP) were injected bilaterally into the ventral tegmental
area (VTA) or nucleus accumbens (NAc) of alcohol preferring (P) rats trained to self-administer ethanol. P450scc overexpression in the
VTA significantly reduced ethanol self-administration by 20% over the 3 week test period. P450scc overexpression in the NAc, however,
did not alter ethanol self-administration. Locomotor activity was unaltered by vector administration to either region. P450scc overex-
pression produced a 36% increase in (3,5)-3-hydroxypregnan-20-one (3,5-THP, allopregnanolone)-positive cells in the VTA, but
did not increase 3,5-THP immunoreactivity in NAc. These results suggest that P450scc overexpression and the resultant increase of
3,5-THP-positive cells in the VTA reduces ethanol reinforcement. 3,5-THP is localized to neurons in the VTA, including tyrosine
hydroxylase neurons, but not astrocytes. Overall, the results demonstrate that using gene delivery to modulate neuroactive steroids
shows promise for examining the neuronal mechanisms of moderate ethanol drinking, which could be extended to other behavioral
paradigms and neuropsychiatric pathology.
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Introduction
Neuroactive steroids are neuromodulators synthesized in the
brain that modulate neuronal activity and influence motivation
and emotional behaviors. The GABAergic neuroactive steroid
(3,5)-3-hydroxypregnan-20-one (3,5-THP or allopreg-
nanolone) is a potent positive allosteric modulator of GABA type
A (GABAA) receptors. GABAA receptors are the primary inhibi-
tory receptors in the brain and mediate many of the behavioral
effects of ethanol. Ethanol-induced increases of 3,5-THP con-
tribute to many of the neurophysiological and behavioral effects
of ethanol in rats (VanDoren et al., 2000;Hirani et al., 2002, 2005)
as well as subjective effects of alcohol in humans (Pierucci-Lagha
et al., 2005). Furthermore, human alcoholics have reduced blood
plasma levels of 3,5-THP during alcohol withdrawal (Romeo
et al., 1996). Moreover, increasing evidence suggests that modu-
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latingGABAergic neuroactive steroid levelsmay have therapeutic
value for treating multiple neurologic and psychiatric disorders
(Marx et al., 2006;Morrow, 2007; Rupprecht et al., 2010; Brinton,
2013).
Neuroactive steroids alter both ethanol reinforcement and
ethanol consumption in rodents. For example, pregnenolone
(Besheer et al., 2010a) and the synthetic GABAergic neuroactive
steroid 3,5-20-oxo-pregnane-3-carboxylic acid (O’Dell et al.,
2005) dose dependently reduce ethanol self-administrationwith-
out producing sedation. Administration of 3,5-THP or the
longer acting synthetic analog of 3,5-THP, ganaxolone, pro-
duces biphasic effects on ethanol self-administration (Janak et al.,
1998; Ford et al., 2005; Besheer et al., 2010a). However, there are
concerns that 3,5-THP and ganaxolone produce sedation
(Belelli et al., 1989; Besheer et al., 2010a), limiting therapeutic
effectiveness. Furthermore, the therapeutic potential of exoge-
nously administered 3,5-THP may also be limited by rapid
metabolism (Purdy et al., 1990).
The mesolimbic pathway is strongly implicated in ethanol
reinforcement and consumption (Koob, 1992; McBride et al.,
1999; Gonzales et al., 2004), and intracerebroventricular admin-
istration of 3,5-THP alters mesolimbic dopamine release
(Motzo et al., 1996; Rouge´-Pont et al., 2002). Therefore, we hy-
pothesized that neuroactive steroids reduce ethanol self-
administration via actions in the nucleus accumbens (NAc)
and/or the ventral tegmental area (VTA). To circumvent limita-
tions of exogenous 3,5-THP administration, such as rapidme-
tabolism and sedation, we used viral vector-mediated gene
delivery to increase neuroactive steroid production in the NAc
or the VTA. The synthesis of neuroactive steroids requires
cholesterol conversion to pregnenolone by the mitochondrial
cytochrome P450 side chain cleavage (P450scc) enzyme, the
rate-limiting enzymatic reaction in steroid synthesis. There-
fore, we constructed a recombinant adeno-associated serotype 2
(rAAV2) vector that overexpresses P450scc in vivo, which should
lead to long-term elevations of neuroactive steroids selectively in
cells that contain the requisite biosynthetic enzymes. Not only
did the viral vector manipulation result in chronically elevated
P450scc expression, pregnenolone synthesis, and levels of 3,5-
THP, but regionally specific P450scc overexpression significantly
influenced long-term operant ethanol self-administration. We
also used confocal imaging to determine cell type-specific local-
ization of 3,5-THP in the VTA.
Materials andMethods
Animals
Adult male Wistar rats (275 g) were obtained from Harlan Laborato-
ries and used for characterizing viral vectors (n  16 for in vivo confir-
mation of P450scc overexpression in the NAc Shell; n  8 to examine
effects of vector infusion on 3,5-THP immunoreactivity in the NAc).
Male rats were chosen for these studies to eliminate the potential con-
founding variable of fluctuating neuroactive steroid levels during the
estrous cycle. The effects of rAAV2-P450scc transduction in the NAc on
operant ethanol self-administration were assessed using adult male
alcohol-preferring (P) rats bred in-house at the University of North Car-
olina at Chapel Hill (UNC). This stock of P rats was derived from breed-
ers of the selected line of P rats provided by Indiana University (courtesy
ofDr. T.K. Li). The effects of rAAV2-P450scc transduction in theVTAon
operant ethanol self-administration and the double-labeling experi-
ments were performed using two cohorts of adult male P rats obtained
from Indiana University. Baseline operant ethanol self-administration
resulted in moderate ethanol consumption and was comparable in all
groups of P rats used for these studies. Animals were double housed until
surgery and single housed thereafter. Home cages were Plexiglas contain-
ing corn cob bedding and food and water was available ad libitum unless
otherwise stated. The colony room was maintained on a normal 12 h
light/dark cycle (light onset at 0700 h). Procedures followed National
Institutes of Health (NIH) Guidelines under UNC Institutional Animal
Care and Use Committee approved protocols. Viral vector use was ap-
proved by the UNC Department of Environmental Health and Safety
Biosafety Committee.
Apparatus
Self-administration chambers. Operant ethanol self-administration was
performed in conditioning chambers measuring 30.5  24.1 cm (Med
Associates) located inside sound-attenuating cubicles. Cubicles were
equippedwith an exhaust fan for ventilation, which alsomasked external
sounds. Both the left and right walls of the chambers contain a lever and
liquid receptacle (i.e., 2 per chamber). The appropriate number of lever
press responses simultaneously activated a stimulus light over the lever
and a syringe pump (Med Associates) that delivered 0.1 ml of liquid
solution into a receptacle over a 1.66 s duration. Lever responses during
reinforcer delivery were counted, but did not result in programmed con-
sequences. The operant chambers were connected to a computer pro-
grammed to control sessions and record the resulting data.
Locomotor chambers. Clear Plexiglas chambers (43.2 43.2 cm; Med
Associates) with 16 photobeams per axis were used to measure locomo-
tor activity in the same animals used in the NAc and VTA operant self-
administration studies. Open field tests took place at 26 d post vector
infusion for the NAc animals and at 4 weeks postinfusion in the VTA
animals. Total horizontal distance traveled (centimeters) was deter-
mined by the number of photobeam breaks during 30 min. Photobeam
breakswere collected via computer interface in 2min time intervals using
Activity Monitor locomotor activity software (Med Associates).
Operant ethanol self-administration
Lever press training. The day before initial training, animals were water
deprived for 24 h. Immediately following water deprivation, animals
were placed in the operant chambers for a 16 h lever press training session
where 0.1 ml of sucrose (10%, w/v) or water were concurrently available
contingent on lever press responses. Lever press responses were initially
maintained on a concurrent fixed-ratio 1 (CONC FR1 FR1) schedule of
reinforcement andwere gradually increased toCONCFR2FR2 following
delivery of 4 reinforcers, followed by a CONC FR4 FR4 schedule after
delivery of 10 reinforcers. Following the 16 h training session animals
were returned to their home cage for a period of 24 h with ad libitum
water access thereafter.
Sucrose fading, operant baseline sessions, and operant self-administration
testing. After the initial training session, rats began daily (M–F) 30 min
sessions on a CONC FR4 FR4 schedule. To facilitate lever pressing for
ethanol, a modified sucrose fading procedure (Samson, 1986) was used
as previously described (Hodge et al., 1993; Besheer et al., 2010b). Briefly,
ethanol was gradually added to the 10% (w/v) sucrose solution and su-
crose was faded out until only 15% (v/v) ethanol maintained lever re-
sponding. The sequence of sucrose/ethanol solutions were as follows:
10% sucrose/2% ethanol (10S/2E), 10S/5E, 10S/10E, 5S/10E, 5S/15E,
2S/15E, and 0S/15E, with two sessions conducted at each concentration.
Following sucrose fading, animals experienced aminimumof 28 baseline
operant self-administration sessions with 15% ethanol versus water. One
week following surgery, animals that received rAAV infusion in the NAc
underwent 14 d of operant testing sessions. Animals that received rAAV
infusion in the VTA underwent 21 d of operant sessions. Ethanol (95%,
w/v, Pharmco-AAPER) was diluted in distilled water to 15% (v/v). Eth-
anol intake (g/kg) was determined from the animal’s body weight and
number of reinforcers received during a session. Using this paradigm we
have previously reported baseline blood ethanol concentrations of 80
mg/dl in P rats with similar response rates (Besheer et al., 2008).
P450scc AAV plasmid construction and virus packaging
An AAV vector plasmid containing P450scc was created similarly as de-
scribed previously (Choi et al., 2006; McCown, 2006). In brief, the
P450scc sequence was amplified frommRNA isolated from the rat olfac-
tory bulbs and converted to cDNA using a SuperScript II reverse-
transcriptase kit (Life Technologies). The primers were designed to
incorporate AgeI and NotI restriction sites in the 5 and 3 portion of the
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sequences, respectively. The sequences of the primers were as follows: (1)
5-ACCGGTATGCTGGCAAAAGGTCTT-3 and (2) 5-GCGGC-
CGCTCATACAGTGTCGCCTTTTCTG-3. The amplified PCR prod-
uct was ligated into a TOPOTA vector as an intermediate step. Digestion
of this intermediate vector with AgeI and NotI resulted in a P450scc
cDNA fragment that was subsequently ligated into an AAV plasmid con-
taining a chicken -actin (CBA) promoter 5 to the AgeI site to drive
P450scc gene expression. Inverted terminal repeats (ITRs) flanked the
-actin promoter and P450scc cDNA sequence (Fig. 1B). This P450scc
clone was sequenced to verify the integrity of the start and stop codons as
well as the cDNA sequence. A single point mutation was noted that
resulted in a nonpolar valine to the smaller nonpolar alanine at amino
acid position 151. This mutation was further determined to be inconse-
quential as verified by increased mRNA and protein expression by re-
verse-transcriptase PCR and Western blot, respectively, in transient
transfected fibroblasts as well as assessment of function via conversion of
22-hydroxycholesterol to pregnenolone via radioimmunoassay (RIA).
Subsequently, the recombinant AAV2- P450scc (rAAV2-P450scc) viral
vector was packaged by the UNC Viral Vector Core (7.5  1011 viral
particles/ml). AAV serotype 2 was used due to its previous success in
infecting neuronal cells, long-term gene expression, and minimal im-
mune response. Control rAAV2-GFP vectors were also obtained from
the UNC Vector Core (5 1011 to 1 1012 viral particles/ml).
Cell culture
Mouse L(tk) fibroblast cells were used as described previously (Harris
et al., 1995), since transfection efficiency is higher in non-neuronal cells.
Briefly, cells were grown in flasks previously coated with poly-L-lysine
usingDMEMwith high glucose (Life Technologies) along with 10% fetal
bovine serum and penicillin-streptomycin. Cells were maintained in a
5% CO2 humidified incubator. To test vector construct, cells were tran-
siently transfected using Lipofectamine (Invitrogen).
P450scc mRNA and protein analysis
Cell and tissue preparation. Cell culture samples were washed with ice-
cold PBS, scraped, and pelleted down by low-speed centrifugation. Rats
received either rAAV2-P450scc or rAAV2-GFP infusions into theNAc or
NAc shell and were killed at 1 week postsurgery for in vivo characteriza-
tion of P450scc overexpression (NAc shell) or at 4 weeks postsurgery
(NAc) following operant self-administration and open field studies.
Brains were rapidly removed, flash frozen using isopentane, and stored
at 80C° until processed. One animal in the NAc operant self-
administration experiments was excluded because the full rAAV2-
P450scc infusionwas not delivered, and an increase in P450scc transcript
indicative of rAAV2-P450scc transduction (100%) was not observed.
mRNA analysis. Total RNA was isolated from microdissected tissue
using TRIzol and converted to cDNA using SuperScript II (Invitrogen)
with randomhexamers. cDNAwas amplified using the primer pair listed
above under plasmid construction with a three-step PCR program. Sam-
ples were subsequently separated using a 1.0% Tris/EDTA gel. cDNA
samples were re-amplified using primers specific to-actin (Whitman et
al., 2013) for normalization. Gel images were acquired using a Fotodyne
imaging cabinet (Fotodyne), and quantified using NIH Image 1.57. Data
were analyzed using Student’s t test.
Western blot analysis. Microdissected NAc shell tissue was homoge-
nized in a whole-cell lysate buffer containing 1% SDS, 1 mM EDTA, and
10 mM Tris. Protein concentrations were determined by a bicinchoninic
acid protein assay. Samples were subsequently denatured and separated
using SDS-PAGE and transferred to polyvinylidene difluoride mem-
branes (Invitrogen). Membranes were probed with an antibody against
P450scc (Millipore). Bands were visualized using enhanced chemilumi-
nescence (GE Healthcare) under nonsaturating conditions. Blots were
then re-exposed to an actin-specific antibody (Millipore) for normaliza-
Figure1. The P450scc construct increases functional P450scc expression resulting in elevated pregnenolone levels.A,Model to enhance neuroactive steroid synthesis by overexpressing P450scc,
which performs the limiting enzymatic reaction in steroidogenesis. B, P450scc construct consisting of the P450scc gene driven by the ubiquitous CBA promoter flanked by ITRs. C, Transient
transfection of mouse (Ltk) fibroblast cells increased P450scc by10-fold ( p 0.001) 48 h post-transfection. Representative immunoblot probed for P450scc with-actin used as a loading
control:	 indicates transfectionwith P450scc construct, indicates control cells.D, Pregnenolone levelswere increased in the cellmedia ( p 0.0001),measured by RIA; *p 0.0001 compared
with control.
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tion. Densitometric analysis was conducted using NIH Image 1.57 and
data were analyzed using Student’s t test.
Surgery and viral vector infusion. Animals were anesthetized with iso-
flurane and placed into a stereotaxic apparatus (David Kopf Instru-
ments). The rAAV2-P450scc or control rAAV2-GFP vectors were
infused bilaterally with a syringe pump (Harvard Apparatus) and 10 l
gastight syringes (Hamilton Company), connected with polyethylene
tubing to needles made from stainless steel 30 gauge tubing (Smallparts).
Needles and tubing were coated with a 10% pluronic F-68 solution
(Sigma-Aldrich) to minimize stainless steel binding of virus. Virus was
infused at 0.2 l/min at a total volume of 2–4 l/hemisphere. Needles
were left in place at the infusion site for an additional 5 min to allow for
virus diffusion. Infusion coordinates relative to bregma were based on
the rat brain atlas (Paxinos andWatson, 1998) as follows: NAc shell (AP
	 1.6, ML
 0.7, DV7.5), NAc (AP	 1.6, ML
 1.5, DV7.5), VTA
(AP  5.5, ML 
 2.0, DV 8.3 with 10° angle). The optimal infusion
volume for each brain region was determined with pilot surgeries using
increasing volumes of the rAAV2-GFP vector. Optimal volumes were
determined by GFP visualization that was limited to the target brain
region. Animals were given 1week to recover from surgery before resum-
ing operant self-administration. VTA needle placements were confirmed
using immunohistochemistry (IHC) for glial fibrillary acid protein
(GFAP). In the NAc experiments brain tissue was freshly frozen. There-
fore, infusions were confirmed by P450scc mRNA increases in the NAc
indicative of successful rAAV2-P450scc transduction (100% increase
in P450scc mRNA). In the NAc shell experiments for in vivo vector char-
acterization all animals were included in the statistical analysis.
IHC
Tissue preparation. Animals were anesthetized with pentobarbital so-
dium (150 mg/kg, i.p.; Professional Compounding Centers of America)
and transcardially perfused with PBS followed by 4% paraformaldehyde.
Tissue was postfixed in 4% paraformaldehyde for 24 h at 4°C, sectioned
coronally at 40 m on a vibrating microtome, and stored at 30°C in
cryoprotectant until further processing.
3,5-THP IHC. 3,5-THP immunohistochemical assays with 3,3-
diaminobenzidine (DAB) detection were performed as previously de-
scribed in detail (Cook et al., 2014a). No detergents or organic solvents
were used to prevent steroid leaching and (three to four sections/animal/
brain region) were analyzed. For fluorescent detection, tissue was rinsed,
blocked and incubated in 3,5-THP antiserum for 48 h at 4°C (1:500)
followed by an Alexa Fluor 488 secondary antibody (Life Technologies).
3,5-THP IHC cell counts. 3,5-THP immunoreactivity with DAB
detection was visualized using an Olympus CX41 light microscope
(Olympus America) and images were captured with a digital camera
(Regita model; QImaging). Image analysis software (Bioquant Life Sci-
ences version 8.00.20) that uses linear integrated optical density was used
for determining positive cell counts. The microscope, camera, and soft-
ware were background corrected and normalized to preset light levels to
ensure fidelity of data acquisition. Positive cell countmeasurements were
calculated from a defined region (e.g., brain region), divided by the area
of the region in square millimeters, and expressed as cell counts/mm2.
Data were acquired from three to four sections/animal/brain region, and
averaged within a brain region for an individual animal to obtain one
value per subject. Immunoreactivity was analyzed using Student’s t test
(Prism; GraphPad Software). Brain region analyses were performed us-
ing histological coordinates as follows: mPFC (four sections correspond-
ing to	3.20,	3.00,	2.70, and	2.20 AP), NAc (three to four sections
corresponding to 	2.20, 	1.70, 	1.60, or 	 1.20 AP), and VTA (four
sections corresponding to5.20/5.30,5.60,5.80, and6.04 AP).
Figure 2. rAAV2–P450scc transduction in the NAc shell increases P450sccmRNA and protein expression dependent on the volume of virus infused.A, Representative photomicrograph (10) of
rAAV2-GFP infection efficiency in the NAc shell 1week after 2l rAAV2-GFP infusion (green, GFP; red, Nissl stain). The red box indicates the location of the representative photomicrograph (	1.60
mmrelative to bregma)within theNAc.B, The 4l infusionof rAAV2–P450scc significantly increasedP450sccmRNA ( p0.005) at 1weekpostsurgery. Representative gel showingP450sccmRNA
following 4l rAAV2–P450scc or rAAV2-GFP infusion in the NAc shell.-Actinwas used as a loading control. C, rAAV2–P450scc transduction increased protein levels of P450scc following both the
2l ( p 0.005) and 4l ( p 0.05) infusions at 1 week postsurgery. Representative immunoblot probed for P450scc following 4l rAAV2–P450scc or rAAV2-GFP infusion in the NAc shell.
P450scc is the uppermost band thatwas increased following rAAV2–P450scc transduction.-Actinwas used as a loading control, but is not seen in the positive control (rat adrenal) due to the small
amount of protein loaded (1g) compared with brain samples;*p 0.05 compared with GFP control, **p 0.005 compared with GFP control.
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All analyses were based on coordinates relative to bregma in theRat Brain
Atlas (Paxinos and Watson, 1998).
GFP and GFAP epifluorescence. Enhanced GFP (eGFP) immunofluo-
rescencewas used to determine infection efficiency of the rAAV2 vectors.
Sections were mounted on microslides, rinsed, blocked, and incubated
with eGFP primary antibody (1:1000;Millipore). Following rinses, slides
were incubated with Alexa Fluor 488 secondary antibody (Life Technol-
ogies) for 1 h at room temperature, rinsed, and finally incubated with a
fluorescent redNissl stain (Life Technologies) to identify neuroanatomi-
cal landmarks. GFAP immunofluorescence was used on free-floating
sections (1:3000; Dako) to determine needle placement of virus injec-
tions in the VTA of P rats (Fig. 5). Following GFAP primary antibody
incubation, sections were rinsed and incubated with Alexa Fluor 594
secondary antibody (Life Technologies). Immunofluorescence was visu-
alized with a Leica DMIRB inverted microscope and images were cap-
tured with a QImaging MicroPublisher camera and computer software.
Double immunofluorescent labeling and confocal microscopy. Tissue
from P rats (n 3) not used in the self-administration studies was used
for double-labeling experiments. Free-floating sections were rinsed,
blocked, and incubated in primary antibody for cell-type specific mark-
ers: TH (1:1000; ImmunoStar), NeuN (1:200; clone 60; Millipore), or
GFAP (1:3000) for 24 h at 4°C. Next, sections were rinsed, blocked, and
incubated with 3,5-THP primary antibody for 48 h at 4°C. Then,
sectionswere rinsed and incubatedwith secondary antibody (Alexa Fluor
488 for 3,5-THP visualization and Alexa Fluor 594 for cell-type spe-
cific markers; Life Technologies). Immunofluorescence was visualized
using a Leica SP2 laser scanning confocal microscope and computer
software. Cell-type markers and 3,5-THP immunofluorescence were
imaged sequentially to prevent fluorophore bleed-through.
RIA
Pregnenolone concentrations were measured using a procedure previ-
ously described in detail (Porcu et al., 2006), modified for use with cell
media. Briefly, pregnenolone was extracted from cell media (spiked with
1000 counts per minute of [ 3H] pregnenolone for recovery) three times
with 3ml of ethyl acetate. The dried extracts were reconstituted in 2ml of
assay buffer, and 0.5ml aliquotswere used for the assay (run in duplicate)
and for recovery measurement. Pregnenolone antibody was purchased
Figure 3. rAAV2–P450scc transduction in the NAc increases P450scc mRNA but does not alter operant ethanol self-administration or cellular 3,5-THP. A, Representative photomicrograph
(10) of rAAV2-GFP infection efficiency in the NAc 1 week after 3l of rAAV2-GFP infusion (green, GFP; red, Nissl stain). The red box indicates the location of the representative photomicrograph
(	1.60 mm relative to bregma) within the NAc. B, rAAV2–P450scc transduction in the NAc did not alter operant ethanol responding or water responding, compared with rAAV2-GFP controls.
Ethanol responding over the 14 d of test sessions is collapsed in the bar graph. C, rAAV2–P450scc transduction in the NAc did not alter mean ethanol intake (g/kg) over the 14 d of test sessions,
compared with rAAV2-GFP controls. D, rAAV2–P450scc transduction in the NAc did not alter total distance traveled (centimeters) in the open field test at 26 d following vector infusions. E, The
infusion of rAAV2–P450scc (3l) significantly increased P450scc mRNA in the NAc at 4 weeks postsurgery. Representative gel showing P450scc mRNA level following 3l rAAV2–P450scc or
rAAV2-GFP infusion in the NAc.-Actin was used as a loading control. F, Infusion of rAAV2–P450scc (3l) in the NAc of Wistar rats did not alter 3,5-THP-positive cells in the NAc at 1 week
postsurgery.G, Representative photomicrographs (10) of cellular 3,5-THP immunoreactivity in theNAc 1week following 3l rAAV2-GFP or rAAV2–P450scc infusion in theNAc. Baseline (BL)
represents 1 week average of ethanol responding during the week before surgery; *p 0.0001 compared with GFP control.
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from MP Biomedicals. Pregnenolone values are expressed as ng/ml cell
media.
Results
P450scc gene delivery increases P450scc and the neuroactive
steroid pregnenolone in L(tk) cells
Overexpression of P450scc increases the rate-limiting enzyme
in steroid synthesis, thereby driving neuroactive steroid
expression (Fig. 1A). To achieve this goal in vivo, P450scc gene
expression was driven by a ubiquitous CBA promoter in
the context of an AAV vector (Fig. 1B). To confirm that the
P450scc construct results in increases of P450scc and steroido-
genesis in vitro, we transiently transfected mouse L(tk) fibro-
blast cells and measured P450scc protein levels as well as
pregnenolone levels in the cell media. Transfection of fibroblasts
with the P450scc construct resulted in a 10-fold increase in
P450scc protein expression at 48 h post-transfection (t(4) 
11.74, p  0.001; Fig. 1C), as well as an increase in extracellular
pregnenolone levels (t(12) 8.360, p 0.0001; Fig. 1D).
Infusion of rAAV2-P450scc in the NAc shell increases P450scc
To verify that rAAV2-P450scc increases P450scc in vivo, we in-
fused the rAAV2-P450scc or rAAV2-GFP vectors at 2 and 4 l
into the NAc shell of Wistar rats and measured mRNA and pro-
tein levels 1 week following surgery. The infection efficiency of
the rAAV2-GFP vector (2l) and location of transductionwithin
the NAc shell (Fig. 2A) was determined 1 week postinfusion. The
4l rAAV2-P450scc infusion increased P450sccmRNAby 573

122% (t(6)  4.532, p  0.005; Fig. 2B) and protein levels were
increased by 84 
 9% following the 2 l infusion (t(6)  6.847,
p 0.005) and by 172
 69% following the 4 l infusion (t(6)
2.479, p 0.05; Fig. 2C).
Overexpression of P450scc in the NAc does not alter 3,5-
THP or operant ethanol self-administration
To determine whether P450scc overexpression in the NAc alters
ethanol reinforcement, we infused the rAAV2-P450scc or
rAAV2-GFP vectors (3 l) into the NAc of P rats trained to
self-administer ethanol. We have previously shown that ethanol
decreases levels of cellular 3,5-THP in the NAc “shore” (core-
Figure 4. rAAV2–P450scc transduction in the VTA produces long-term reductions in operant ethanol self-administration and increases 3,5-THP-positive cells. A, Representative photomi-
crograph (10) of rAAV2-GFP infection efficiency in the VTA 1 week after 2 l rAAV2-GFP infusion (green, GFP; red, Nissl stain). The red box indicates the location of the representative
photomicrograph (5.80mm relative to bregma) within the VTA. B, rAAV2–P450scc transduction in the VTA reduced operant ethanol ( p 0.005) but not water responding over the 21 d of test
sessions, comparedwith rAAV2-GFP controls. Mean ethanol responding over the 21 d of test sessions is collapsed in the bar graph. C, rAAV2–P450scc transduction in the VTA reducedmean ethanol
intake (g/kg; p 0.01) over the 21 d of test sessions, compared with rAAV2-GFP controls.D, rAAV2–P450scc transduction in the VTA did not alter total distance traveled (centimeters) in the open
field test at 4weeks following vector infusions. E, Infusion of rAAV2–P450scc (2l) in the VTA increased 3,5-THP-positive cells in the VTA ( p 0.005) at 4weeks postsurgery. F, Representative
photomicrographs (10) of cellular 3,5-THP immunoreactivity in the VTA 4weeks following 2l rAAV2-GFP or rAAV2–P450scc infusion in the VTA. Baseline (BL) represents 1week average of
ethanol responding during the week before surgery; *p 0.01 and **p 0.005 compared with control values.
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shell border; Cook et al., 2014a), and others have shown that
dopamine is released in the NAc shore during operant self-
administration of ethanol (Howard et al., 2009). Therefore, we
aimed our viral infusions (3 l) at the NAc shore, which is also
centralized within the NAc and thereby limits viral infection of
surrounding brain regions (Fig. 3A). All ethanol self-administration
data were analyzed using two-way repeated-measures ANOVA
across all test sessions. P450scc overexpression in the NAc did not
alter operant ethanol responding (main effect of rAAV2-P450scc
treatment; F(1,156)  2.297, p  0.1555; Fig. 3B). There was no
difference in ethanol intake (main effect of rAAV2-P450scc treat-
ment; F(1,156) 2.186, p 0.1651), which averaged 1.14
 0.12
g/kg for the rAAV2-P450scc group and 0.94 
 0.07 g/kg for the
rAAV2-GFP group during the 14 d of testing. Furthermore, there
was no difference in water-responding (F(1,156)  0.0048, p 
0.9457; Fig. 3B) or general locomotor activity (t(12) 1.813, p
0.0948; Fig. 3D) between the rAAV-P450scc and rAAV-GFP
groups. The rAAV-P450scc vector did, however, increase P450scc
mRNA levels in the NAc 4 weeks following infusion (t(12) 6.690,
p  0.0001; Fig. 3E). To determine whether rAAV2-P450scc infu-
sion in the NAc increases 3,5-THP, we infused the rAAV2-
P450scc or control vector into the NAc of a separate group of
Wistar rats and performed 3,5-THP IHC at 1 week following
infusion. IHC analysis revealed that rAAV2-P450scc did not in-
crease 3,5-THP in the NAc (t(6) 0.1893, p 0.86; Fig. 3G).
Overexpression of P450scc in the VTA reduces long-term
operant ethanol self-administration
To test whether P450scc overexpression in theVTA alters ethanol
reinforcement, we infused the rAAV2-P450scc or rAAV2-GFP
vectors (2 l) into the VTA of P rats trained to self-administer
ethanol. rAAV2-P450scc infusion in the VTA reduced ethanol
responding by 20% (main effect of rAAV2-P450scc treatment:
F(1,540) 13.67, p 0.005; main effect of time: F(20,540) 2.785,
p  0.0001; Fig. 4B) and ethanol intake by 14% (main effect of
rAAV2-P450scc treatment: F(1,540) 8.174, p 0.01; main effect
of time: F(20,540)  3.092, p  0.0001; Fig. 4C) over the 21 d of
testing. Viral infusion did not affect water responding (F(1,540)
0.4870, p 0.4912; Fig. 4B) or general locomotor activity (t(27)
0.5534, p 0.5845; Fig. 4D). There was a main effect of time on
water responding (F(20,540) 1.643, p 0.05) due to higherwater
responding on the initial days following surgery, which over the 3
weeks stabilized at a lower level for both groups. The reduction in
ethanol reinforcement and consumption was associated with an
increase in 3,5-THP-positive cells in the VTA of animals that
received rAAV2-P450scc infusion (t(27)  3.104, p  0.005;Fig.
4E,F). Since viral infusions may increase 3,5-THP in projec-
tion sites of the VTA, we also measured 3,5-THP immunore-
activity in the NAc and mPFC. There was no difference in
3,5-THP-positive cells in the NAc (t(13) 1.108, p 0.28) or
mPFC (t(13) 0.7394, p 0.47) of animals that received rAAV2-
P450scc infusion in the VTA (data not shown). Needle place-
ments were determined by using GFAP immunohistochemistry
(Fig. 5).
3,5-THP colocalizes with TH and NeuN in the VTA
To identify cell types inwhich 3,5-THP is localized in theVTA,
we used scanning laser confocal microscopy and double labeled
with NeuN (neuronal marker), GFAP (astrocyte marker), or TH
(putative dopamine cell marker) in P rats (n 3) not included in
behavioral studies. We found that 3,5-THP is located in neu-
rons in the VTA (Fig. 6A), but does not appear to be present in
astrocytes (Fig. 6B). 3,5-THP was located in all TH-positive
neurons examined (294 cells) as well as TH-negative neurons
(Fig. 6C, arrows).
Discussion
In the present study we developed a viral vector to overexpress
P450scc, and drive long-term neurosteroid production in neu-
rons that contain the necessary biosynthetic enzymes. We
Figure 5. Localization of viral vector infusions was determined using GFAP immunofluorescence to visualize needle tracts. A, Representative image showing GFAP immunofluorescence (red) at
the needle tract and GFP-positive cells (green) in the VTA 4 weeks following rAAV2-GFP infusion. The red box indicates the location of the representative image (5.20 mm relative to bregma)
within the VTA. B, Location within the VTA of rAAV2-GFP (green circles) or rAAV2–P450scc (black circles) infusions, relative to bregma.
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showed that P450scc overexpression in the NAc does not alter
ethanol self-administration or 3,5-THP levels. However,
rAAV2-P450scc infusion in the VTA produced persistent reduc-
tions in ethanol self-administration over the 21 d of testing. The
effects of rAAV2-P450scc transduction in the VTA appear to be
specific to ethanol responding since there was no effect on
water-responding or motor activity. Furthermore, reduced
ethanol self-administration was associated with a 36% in-
crease in 3,5-THP-positive cells in the VTA. However,
3,5-THP immunoreactivity was not altered downstream in
theNAc or themPFC. It appears that rAAV2-P450scc infusion in
the VTA produces long-term reductions in ethanol reinforce-
ment by increasing neurosteroids, including 3,5-THP in the
VTA. Further investigation revealed that 3,5-THP is localized
to both TH-positive andTH-negative VTAneurons, but does not
appear to be present in cells labeled with GFAP.
The ability of rAAV2-P450scc transduction of VTA neurons
to modulate ethanol self-administration is likely due to modula-
tion of neural circuitry via GABAA receptor-mediated neuronal
inhibition. The available data suggest that increasing 3,5-THP
within a cell reduces the excitability of that particular cell (Saal-
mann et al., 2006; Akk et al., 2007; Tokuda et al., 2010, 2011).
Therefore, rAAV2-P450scc transduction of a cell most likely pro-
duces a presynaptic inhibitory effect. It is not clear how 3,5-
THP accesses the neuroactive steroid transmembrane binding
sites on GABAA receptors, but it has been proposed to occur via
intracellular (i.e., presynaptic) lateral diffusion through the cell
membrane (Akk et al., 2007) or by a paracrine or autocrinemech-
Figure 6. Confocal scanning microscopy revealed that 3,5-THP colocalizes with NeuN-positive neurons and TH-positive neurons, but not GFAP-positive astrocytes in the VTA of P rats. A,
3,5-THP (green) colocalizes with NeuN (red) in the VTA. B, 3,5-THP (green) does not colocalize with GFAP (red) in the VTA. C, 3,5-THP (green) colocalized with all TH (red)-positive cells
examined in the VTA (294 cells). 3,5-THP is also located in TH-negative cells in the VTA (yellow arrows).
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anism (Herd et al., 2007), as no active release mechanism has
been identified. In the present study, we ascertained that 3,5-
THP is located inTH-positive dopamine neurons in theVTA, but
we cannot rule out the possibility that glutamatergic or GABAe-
rgic neurons were also transduced. It is important to note that
TH-positive dopamine cells in the VTA co-release glutamate in
the NAc shell during optical stimulation (Stuber et al., 2010),
therefore, rAAV2-P450scc transduction of TH-positive neurons
in the VTA may reduce glutamatergic as well as dopaminergic
activity. Furthermore, a recently characterized group of TH-
positive VTA neurons that project to the lateral habenula (LHb)
have been shown to produce reward when optically stimulated
(Stamatakis et al., 2013). Therefore, it is possible that ethanol
reinforcement was reduced by neuroactive steroid elevations in
these LHb projecting cells of the VTA. Further experimentation
will be needed to understand how local increases of 3,5-THP
in the VTA alter mesolimbic activity and identify cell types im-
portant in these effects.
It is also likely that rAAV2-P450scc transduction of VTA neu-
rons altered their response to ethanol. Since ethanol is thought to
disinhibit dopamine neurons (Spanagel and Weiss, 1999), in-
creased 3,5-THP in these cells may alter the ability of ethanol
to produce this effect. Indeed increased 3,5-THP in the VTA
may shift the dose–response of ethanol, increasing ethanol sensi-
tivity, since 3,5-THP and ethanol both modulate GABAA re-
ceptors. In addition, rAAV2-P450scc transduction of the VTA
may have also influenced 3,5-THP in glutamatergic afferent
projection neurons from the PFC or pedunculopontine tegmen-
tal nucleus (PPTg)/laterodorsal tegmental nucleus (LDT), for ex-
ample. These neurons provide excitatory control over dopamine
neurons, and if inhibited by increased 3,5-THP, a decrease in
dopamine neuron activity could be a possible outcome. In con-
trast, if 3,5-THP is increased in the glutamatergic cells that
synapse onto the GABAergic interneurons, which normally in-
hibit dopamine neurons, we would expect an increase in dopa-
minergic activity. The bed nucleus of the stria terminalis (BNST)
sends both GABAergic and glutamatergic afferent projections to
the VTA that predominately synapse on TH-negative GABAergic
neurons (Kudo et al., 2012). Optical stimulation of these projec-
tions produce opposing effects on reward and aversion (Jennings
et al., 2013), with stimulation of the GABAergic projection pro-
ducing reward and stimulation of the glutamatergic projection
producing aversive behavior. Therefore, although it is unclear
how, increases of 3,5-THP in the VTA from BNST afferent
projections may play a role in our behavioral results. There are
several ways that increased intracellular 3,5-THP could di-
minish ethanol-induced VTA activity and/or excitability via local
intracellular-mediated neuronal inhibition, which may conse-
quently result in reduced ethanol self-administration (Fig. 7).
Alternatively, 3,5-THP could be “released” or diffuse to
produce extracellular actions. If 3,5-THP is released from
VTA neurons, the main theoretical consequence would be inhi-
bition of interneurons. In contrast to reducing VTA dopamine
cell activity, 3,5-THP inhibition of GABAergic interneurons
would likely increase dopamine activity (Tan et al., 2010). Phar-
macologic manipulations in the NAc and VTA suggest reduced
dopamine activity is associated with a reduction in the mainte-
nance of operant ethanol self-administration in nondependent
rats (for review see, Gonzales et al., 2004). Therefore, it is unlikely
that increased release of 3,5-THP was the predominant effect
of rAAV2-P450scc transduction in the VTA. Finally, we cannot
rule out the possibility that rAAV2-P450scc transduction of VTA
involves several of these mechanisms resulting in the overall be-
havioral sequelae observed. Ultimately, using a viral vector to
Figure7. Simplified schematic of potentialmechanismsof rAAV2–P450scc transduction-inducedeffects onVTAneuronsbelieved to regulate ethanol reinforcement and consumptionor inwhich
optical stimulation is rewarding. Transduction of TH	 neuronsmay reduce activity in cells that project to either the (A) NAc,mPFC, and/or the (B) LHb. Transduction of afferent projections from (C)
PFC or PPTg/LDT may decrease activation of TH	 projection neurons. Transduction of (D) BNST afferent projections onto GABAergic neurons have the potential to influence rewarding and/or
aversive behavior. Transduction of inhibitory interneurons in the VTA is not expected to have any effect since biosynthetic enzymaticmachinery is absent in these cells, but (E) increased extracellular
levels of 3,5-THP may act via GABAergic interneurons to increase activity of TH	 neurons.
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target neuron types selectively may identify cell types/circuitry in
the VTA that contribute to the current behavioral findings.
The inability of rAAV2-P450scc transduction in the NAc to
alter operant ethanol responding may be due to the lack of in-
crease of 3,5-THP in NAc neurons that regulate ethanol self-
administration. It is surprising that rAAV2-P450scc transduction
in the NAc did not increase cellular 3,5-THP levels. Previous
studies have shown dense cellular staining of 3,5-THP in the
striatum (Saalmann et al., 2007; Cook et al., 2014a,b), suggesting
that the necessary biosynthetic enzymes are present in NAc neu-
rons. However, we have recently shown acute ethanol adminis-
tration reduces 3,5-THP immunoreactivity in the NAc shore,
in contrast to many other brain regions that display an ethanol-
induced increase of 3,5-THP (Cook et al., 2014a,b). Therefore,
regulation of 3,5-THP synthesis and/or metabolism may dif-
fer in the NAc, compared with other brain regions. Nonetheless,
the observation that rAAV2-P450scc transduction ofNAcdid not
alter local 3,5-THP levels or ethanol self-administration sup-
ports the idea that 3,5-THP may be requisite for the effects of
rAAV2-P450scc transduction of the VTA.
Limitations of the current study include the lack of measure-
ment of other neurosteroids, and the lack of a palatable control
reinforcer. It is likely that other neurosteroids, including proges-
terone, deoxycorticosterone, and additional neuroactive metab-
olites were increased in the VTA, which may have contributed to
the results. Transfection of the P450scc construct increases preg-
nenolone, and systemic pregnenolone administration increases
many neuroactive steroids (Porcu et al., 2009). Pregnenolone
administration also reduces ethanol reinforcement (Besheer et
al., 2010a). It is important to note that water responding was low,
indicating a floor effect may apply to this measure. Therefore,
sucrose or saccharin self-administration would be a more opti-
mal reinforcer to determine the specificity of the effects of
rAAV2-P450scc.
The results in the current studies underscore the importance
of endogenous GABAergic neuroactive steroids in the regulation
of neurotransmission across the brain, and potential for thera-
peuticmanipulation. Since these steroids are synthesized in brain
circuitry and other endocrine organs, they provide a mechanism
for interactions between many organ systems, integrating effects
of all the neuroendocrine axes. Therefore, it is not surprising that
alcohol use disorders are impacted by stress, gender, and neuro-
immune processes that are all affected by neuroactive steroids.
Since plasma 3,5-THP levels are reduced duringwithdrawal in
human alcoholics (Romeo et al., 1996), this target merits further
investigation.
Genetic regulation of neurosteroid levels has multiple advan-
tages over systemic administration of neuroactive steroids or
their analogs. First, the effects of rAAV transduction persist in the
CNS at least 2 years in rats (Klein et al., 2002), 8 years in rhesus
monkeys (Hadaczek et al., 2010), and is considered a permanent
episomal modification of the genetic content of the cell. Indeed,
the effects on ethanol self-administration in the present study
persisted for 3 weeks, and showed no sign of diminishing. This is
a critical factor for biomedical research examining chronic dis-
eases such as addictive disorders. Next, it is possible to minimize
unwanted side effects by producing steroidogenesis at sites exhib-
iting pathological activity, avoiding sites that confer unwanted
neuroactive steroid effects. Indeed, we have recently found that
chronic intermittent ethanol administration reduces 3,5-THP
immunolabeling in the VTA, but not the NAc shell (Maldonado-
Devincci et al., 2014), and this effect is associated with increased
ethanol consumption (Becker and Lopez, 2004). Thus, the pres-
ent data converge with other studies upon the conclusion that
modulation of VTA neuroactive steroids regulates ethanol rein-
forcement and drinking. Therefore, the combination of P450scc
gene delivery with studies of brain activity could allow targeted
manipulation of abnormal cellular activity that may underlie al-
cohol use disorders or other neurological or psychiatric disease.
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